Results
1 -
8 of
8Potential Role of IMiDs and Other Agents as Therapy for Myeloma Bone Disease, Myeloma Bone Disease A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis, Clinical Rheumatology Differential Pharmacological Behaviour of p38 Inhibitors in Regulating the LPS-Induced TNF-?? Production in Human and Rat Whole Blood In Vitro, Inflammation p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro, Dermatology and Therapy Signal transduction inhibitors in treatment of myelodysplastic syndromes, Journal of Hematology & Oncology R&D news from ACR/ARHP, Inpharma Weekly